Skip to main content
Clinical Trials/NCT01823744
NCT01823744
Completed
Not Applicable

A New Strategy to Analyze Gene-Nutrient Interaction in Children and Adolescents

Société des Produits Nestlé (SPN)1 site in 1 country146 target enrollmentMarch 2013
ConditionsGenomic

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Genomic
Sponsor
Société des Produits Nestlé (SPN)
Enrollment
146
Locations
1
Primary Endpoint
SAM/SAH ratio
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this trial is to better define how individuals with different genetic make-ups will require different interventions to improve their methylation potential and nutrient status.

Detailed Description

Despite the increasing incidence of overweight and obesity among children, nutritional deficiencies are still a concern. A low intake of vitamins and minerals is associated with a reduction in the antioxidant capacity. Some vitamins are associated with chronic diseases including overweight and obesity. S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) are the substrate and product of essential reactions; the SAM:SAH ratio has been associated with health and is an indicator of cellular DNA methylation potential. Low level of this ratio may affect short and long term health. In this explorative knowledge building open interventional study, subject to be enrolled are children or adolescents 9 to 13 years of age per year (n=180 per year, over 2 years). The study consists of 6 weeks nutritional intervention followed by a 6 weeks follow up. In this study, genomics, proteomics, lipidomics analysis will be performed, in addition to biochemistry, hematology and vitamins analysis.

Registry
clinicaltrials.gov
Start Date
March 2013
End Date
June 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Société des Produits Nestlé (SPN)
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children or adolescents 9 to 13 years of age.
  • Clinically stable.
  • Normal weight, overweight and obese.

Exclusion Criteria

  • Disease diagnosis.
  • At least one episode of axillary temperature \>37°C over the prior 15 days.
  • Three or more episodes of liquid or semi-liquid stools over the prior 24 hours.
  • Supplementation with vitamins and/or minerals.
  • On a supervised diet for reducing weight or any other type of diet restriction.
  • Currently participating or having participated in another clinical study during the last 4 weeks prior to the beginning of this study.

Outcomes

Primary Outcomes

SAM/SAH ratio

Time Frame: baseline and after 6 weeks of product intake

Change from baseline in the correlation between the SAM/SAH ratio in erythrocytes, dietary intakes and, polymorphisms in genes associated with micronutrients

Secondary Outcomes

  • SNP arrays, proteomics, metabolomics, micronutrient levels(baseline, after 6 weeks of product intake and after 6 weeks of follow up)
  • SAM/SAH ratio(after 6 weeks product intake and after 6 weeks of follow up)

Study Sites (1)

Loading locations...

Similar Trials